Century Therapeutics (IPSC) Net Income Growth (1y) (2021 - 2026)
Century Therapeutics (IPSC) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,802.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Century Therapeutics | 419.84 Mn | 285.04 Mn | - | -218.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -218.75% |
| Dec 31, 2025 | 73.24% |
| Sep 30, 2025 | -10.24% |
| Jun 30, 2025 | -4.27% |
| Mar 31, 2025 | 372.82% |
| Dec 31, 2024 | 9.45% |
| Sep 30, 2024 | 4.57% |
| Jun 30, 2024 | 6.26% |
| Mar 31, 2024 | 10.24% |
| Dec 31, 2023 | -24.35% |
| Sep 30, 2023 | -6.41% |
| Jun 30, 2023 | -7.43% |
| Mar 31, 2023 | 16.66% |
| Dec 31, 2022 | -12.54% |
| Sep 30, 2022 | -18.22% |
| Jun 30, 2022 | -33.15% |
| Mar 31, 2022 | -104.45% |
| Dec 31, 2021 | -95.26% |
| Sep 30, 2021 | -96.84% |
| Jun 30, 2021 | -49.30% |